MK-7288

CAS No. 936626-07-2

MK-7288 ( MK7288;MK 7288 )

Catalog No. M16708 CAS No. 936626-07-2

A novel histamine H3 receptor inverse agonist for the treatment of sleep apnoea syndrome.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MK-7288
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel histamine H3 receptor inverse agonist for the treatment of sleep apnoea syndrome.
  • Description
    A novel histamine H3 receptor inverse agonist for the treatment of sleep apnoea syndrome; significantly prolongs MWT sleep latency, and improves car driving simulation standard deviation of lane position in clinical trials.Sleep Disorder Phase 1 Clinical
  • Synonyms
    MK7288;MK 7288
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    Histamine Receptor
  • Research Area
    Neurological Disease
  • Indication
    Sleep Disorder

Chemical Information

  • CAS Number
    936626-07-2
  • Formula Weight
    401.51
  • Molecular Formula
    C22H31N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN(CCN1CCCCC1)C(=O)C2CCC3(CC2)C4=C(C(=O)O3)N=C(C=C4)OC
  • Chemical Name
    (1r,4r)-2'-methoxy-N-methyl-7'-oxo-N-(2-(piperidin-1-yl)ethyl)-7'H-spiro[cyclohexane-1,5'-furo[3,4-b]pyridine]-4-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sun H, et al. J Clin Pharmacol. 2013 Dec;53(12):1294-302.
molnova catalog
related products
  • Hydroxyzine free bas...

    Hydroxyzine is an antagonist of histamine H1-receptor. Hydroxyzine is an antihistaminic with sedative properties used in the control of anxiety and emesis.

  • Orphenadrine hydroch...

    Orphenadrine is an anticholinergic drug of the ethanolamine antihistamine class with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions, as well as the treatment of some aspects of Parkinson's disease.

  • JNJ-5207852 dihydroc...

    JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor. JNJ-5207852 is a potent dibasic amine antagonist that binds potently to rat H3 receptors (Ki=1.2?nm), and has good brain penetration. In ex vivo binding studies in mice, the compound had an ED50 of 0.13?mg?kg?1, subcutaneously.